ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Carolina » Geriatric Medicine

Top Geriatric Medicine Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KAYCEE SINK MD

Geriatric Medicine

209

$33.5K

51
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 25%

$160
Average prescription price

Avg: $58

MARGARET NOEL M.D.

Geriatric Medicine

276

$49.8K

48
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 25%

$180
Average prescription price

Avg: $58

MITCHELL HEFLIN M.D.

Geriatric Medicine

541

$31.1K

58
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $58

SHIV KHOSLA

Geriatric Medicine

788

$39.1K

85
40 are 65+

22%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $58

JEFF WILLIAMSON MD

Geriatric Medicine

854

$58.1K

56
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $58

LAURA HANSON MD

Geriatric Medicine

857

$43.7K

46
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $58

TERRENCE HOLT MD

Geriatric Medicine

948

$41.7K

61
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $58

FRANKLIN WATKINS MD

Geriatric Medicine

1,014

$57.1K

61
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $58

GARY WINZELBERG MD

Geriatric Medicine

1,417

$78.8K

70
70 are 65+

16%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $58

MOBOLANLE GBADAMOSI M.D.

Geriatric Medicine

1,797

$93.8K

129
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

11%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $58

MICHELE HABER MD, MS, MPH

Geriatric Medicine

1,841

$108K

38
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $58

TERRI BYRD M.D.

Geriatric Medicine

1,891

$90.6K

141
122 are 65+

12%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $58

MARK WILLIAMS M.D.

Geriatric Medicine

1,955

$119K

146
128 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $58

BILAL AHMAD M.D.

Geriatric Medicine

2,009

$135K

145
108 are 65+

21%
patients receiving schedule two controlled substances

Avg: 12%

10%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $58

BEATA SKUDLARSKA M.D.

Geriatric Medicine

2,053

$200K

185
182 are 65+

6%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$97
Average prescription price

Avg: $58

RACQUEL DALEY-PLACIDE M.D.

Geriatric Medicine

2,172

$119K

103
103 are 65+

14%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $58

JAMEHL SHEGOG MD

Geriatric Medicine

2,189

$123K

126
125 are 65+

10%
patients receiving schedule two controlled substances

Avg: 12%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $58

MAC GREGANTI MD

Geriatric Medicine

2,210

$153K

112
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $58

HEIDI WHITE M.D.

Geriatric Medicine

2,242

$122K

193
192 are 65+

9%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $58

CHRISTINE KHANDELWAL MD

Geriatric Medicine

2,335

$146K

124
97 are 65+

15%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $58

HOLLY COWARD M.D.

Geriatric Medicine

2,372

$97.8K

119
119 are 65+

15%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $58

AMOS PAGTER M.D.

Geriatric Medicine

2,441

$134K

96
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

18%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $58

GWENDOLEN BUHR M.D.

Geriatric Medicine

2,502

$167K

112
112 are 65+

16%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $58

MARY LYLES MD

Geriatric Medicine

2,858

$139K

123
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

9%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $58

KIMBERLY JOHNSON M.D.

Geriatric Medicine

2,885

$166K

73
61 are 65+

48%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank